Antiemetic prophylaxis with ondansetron and methylprednisolone vs metoclopramide and methylprednisolone in mild and moderately emetogenic chemotherapy

Journal of Pain and Symptom Management

Volumn 18, Issue 3, 1999, Pages 218-222

  Tsavaris, Nicholas B ^a   Koufos, Christos ^a   Katsikas, Michael ^a   Dimitrakopoulos, Adonis ^a   Athanasiou, Eleni ^a   Linardaki, Garyfalia ^a  

^a Univ A   (Greece)

Author keywords

Antiemetic Prophylaxis; Methylprednizolone; Metoclopramide; Nausea vomiting ondansetron

Indexed keywords

ANTIEMETIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; METHYLPREDNISOLONE; METOCLOPRAMIDE; ONDANSETRON;

ADULT; ARTICLE; BOLUS INJECTION; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CONSTIPATION; DIARRHEA; DRUG COST; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; OVARY CANCER; PROPHYLAXIS; VOMITING;

ANTIEMETICS; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; METHYLPREDNISOLONE; METOCLOPRAMIDE; MIDDLE AGED; ONDANSETRON; VOMITING;

EID: 0032886139     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(99)00071-8     Document Type: Article

References (11)

1. Del Favero A., Roila F., Tonato M. Reducing chemotherapy-induced nausea and vomiting. current perspectives and future possibilities Drug Safety. 9:1993;410-428.
2. Roila F., Tonato M., Ballatori E.et al. Comparative studies of various antiemetic regimens. Support Care Cancer. 4:1996;270-280.
3. dexamethasone versus breast metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Lancet. 340:1992;96-99.
4. Tsavaris N., Tsaroucha-Noutsou E., Bacoyiannis C., Mylonakis N., Valilis P., Kozatsani-Halividi D., Tsoutsos H., Droufakou S., Kosmidis P. Antiemetic efficacy of high dose metoclopramide and dexamethasone in patients receiving cisplatin chemotherapy. a randomized study Oncology. 49:1992;479-483.
5. Tsavaris N., Mylonakis N., Bacoyiannis C., Katsikas M., Lioni A., Kosmidis P. Comparison of ondansetron (GR 38032F) vs ondansetron plus methylprednisolone as antiemetic prophylaxis during cisplatin containing chemotherapy. J Pain Symptom Manage. 9:1994;254-257.
6. Gralla R. Approaches to management of emesis. Clinician. 6:1988;26-39.
7. Miller A., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 47:1981;207-217.
8. Van Elteren P.H. On the contribution of independent two sample test of Wilcoxon. Bulletin Int Statist Inst. 12:1960;351-361.
9. Machin D., Campbell M.J. Statistical tables for the design of clinical trials. 1987;Blackwell, Oxford.
10. Campbell M.J. Statistical tables for the design of clinical trials. 1987;79-83 Blackwell, Oxford.
11. Dixon W.J., Massey F.J. Jr. Introduction to statistical analysis. 4th ed:1983;McGraw-Hill, New York.